Birdwatch Archive

Birdwatch Note

2023-01-31 22:33:29 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Oelrich was speaking about how the acceptance of a biotech innovation like mRNA COVID-19 vaccines was an example of how cell and gene therapies, another biotech innovation, could be received by the public, NOT that Covid vaccines themselves were “gene therapy.” https://www.reuters.com/article/factcheck-bayer-vaccine-idUSL1N2YF1AI

Written by 5E040F73C840A11BF57DDAD485BAE870C17795DE713F92915F4BC5FB2D01E4C4
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1620154400550572032

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1620550865550712832
  • noteId - 1620550865550712832
  • participantId - 5E040F73C840A11BF57DDAD485BAE870C17795DE713F92915F4BC5FB2D01E4C4
  • noteAuthorParticipantId -
  • createdAtMillis - 1675204409382
  • tweetId - 1620154400550572032
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Oelrich was speaking about how the acceptance of a biotech innovation like mRNA COVID-19 vaccines was an example of how cell and gene therapies, another biotech innovation, could be received by the public, NOT that Covid vaccines themselves were “gene therapy.” https://www.reuters.com/article/factcheck-bayer-vaccine-idUSL1N2YF1AI

Note Ratings

rated at rated by
2023-02-03 08:07:10 -0600 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 Rating Details
2023-01-31 18:26:53 -0600 2615C01F5D051C7D77A59A9CA03B7D7E35B0749DF8A2C7BEDF30E7F28D201C22 Rating Details
2023-01-31 23:40:38 -0600 2B0FA6BCBB3B813FA16797B92DDAAFE3AEF2D02CEE4ACD152945691D937BC3AC Rating Details
2023-02-01 00:33:00 -0600 32C5D0D27FE0F42045C1A448EE44E5132D0394EFD676F346B100598F37025166 Rating Details
2023-01-31 17:11:54 -0600 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 Rating Details
2023-02-01 04:23:38 -0600 3871C986B3C2BCF97D13633DBD3E4A728BFB2C0C9317A7E7E2E70475092E58E0 Rating Details
2023-01-31 18:03:28 -0600 4B1429D6885919E358CFCE8B1A0E97C6E11A5F7DF1CDE08B3F1E91F17AA41779 Rating Details
2023-02-01 01:39:55 -0600 51B13D07F34597557A8A2E9739C50061D5623C70373E4B9AD6882031050595BF Rating Details
2023-02-01 00:17:14 -0600 5794EE496C1EDE35167B84C87740F7BACF2C09121B3E43869520EEAF31819C7A Rating Details
2023-01-31 20:01:23 -0600 5B66C2C2840AD455FDAC3D1F25BF92AD35DB04D16E6BE11F99C2E62BAC83F418 Rating Details
2023-02-01 05:24:55 -0600 66E65E029587E0660CB3BCDC294F69822E9AB36998D880C702CD1B4414D20A3F Rating Details
2023-02-01 00:01:42 -0600 67D893E95BD9A2E8419DF1D8EFF62FDA0F2CE0FCCA91965447364AA41EB9492C Rating Details
2023-01-31 22:10:31 -0600 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Rating Details
2023-01-31 22:12:12 -0600 8657A9C90C36864B5E9E502E7F406D82BA48A6827E749384964F668B6B3FAAC3 Rating Details
2023-01-31 22:34:00 -0600 8A25DEBD213B957DB33B044988772AAAA446601C651CE257AF5CA981A6844504 Rating Details
2023-02-01 01:25:05 -0600 8DA9658F7AC013B334E1B3B7674A875546D9E30C539C38DDB1039349F60EE18A Rating Details
2023-01-31 17:19:09 -0600 93933023E3A3264C171C2ED37BA80A8D8D66B339AAFEC0C1512F28013F69D76D Rating Details
2023-01-31 17:39:26 -0600 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 Rating Details
2023-02-01 01:33:12 -0600 98AADDB3DEE7AC041D469EC1981958104C338ECB70DD8593808082257CF0008E Rating Details
2023-01-31 17:12:46 -0600 98AC1FAF7D0CA5C5AB880997C891D5521400F723A0A9284A679F410DE99522CA Rating Details
2023-01-31 22:31:00 -0600 9A3BF93B004A7D323E676BDB93F1E787FBB9C339DE51B9A4E3F3C91C32AC722B Rating Details
2023-02-01 00:30:00 -0600 9DC8383A7C114CFC1FC2A9681BECE9F634EEC1A5FB37BB7DA8F6429F1B812153 Rating Details
2023-01-31 17:25:51 -0600 ACBCFB482C41D15AF0671A4EFE6A5D00C7964D3957A6A1FD6B9FEBCCFADB4C69 Rating Details
2023-02-01 04:28:16 -0600 AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 Rating Details
2023-01-31 17:51:00 -0600 B1C7E71679DA008F29C0112F5907CD20FFD18EABF37DFF5E99217FBED5D03B57 Rating Details
2023-02-01 02:33:24 -0600 B295EDC256417DE3C49B8E928AD66670A63731867473D91428DFC5663DD7F7CF Rating Details
2023-01-31 23:59:58 -0600 B8EDF4126506EFFAE0C7C40AF24C78C8F5A268DFD8759E8599BEA01FDE0092F8 Rating Details
2023-01-31 19:31:06 -0600 BAF0C3FA9C1CE1DA64F07804AF7C7E25503BB91C5E0FAB0110A67821B0D2281B Rating Details
2023-01-31 22:20:40 -0600 BF882B8CCE8431F434F8AC7B9DB591B5DD86C5E171368F9282CF2FAEF332F328 Rating Details
2023-01-31 16:41:37 -0600 C56E7751C1802934CA2D97192CE89A429F997B880EF93444A6ECE9C1C1499C9B Rating Details
2023-02-01 00:16:57 -0600 C8B9BD2BDF29EC5C40217C515633DC9820B59FA020161F2B5EC0B84895BB6638 Rating Details
2023-01-31 22:06:01 -0600 C99BA22C736F67A182E48C25F4F74B22FF16300701501AC7E025C2DE3E8D8A98 Rating Details
2023-01-31 21:40:31 -0600 C9C091494878C5B24A029ACBDFFB9988E0EA5BA568BEF216B8741012EFF840C9 Rating Details
2023-01-31 23:09:22 -0600 D94BE300140E6050B78247CA646E974F0735A61AF3720260B1921500511590FD Rating Details
2023-02-01 02:30:15 -0600 DA69DC74B1CCBCAC8046BA96B039BB8F733D6F3A3D8FCDBE70499B21957F20F8 Rating Details
2023-01-31 16:42:25 -0600 F84E584F3C7EB8A928906A4349ABC2EFD6A7F8086F61C5F906B749756E607E5A Rating Details
2023-02-01 01:19:33 -0600 F91C081A837C36DDE69E8B4349FA7757E1A3E5B9A1655460D1ADDD0A013A1CA6 Rating Details
2023-01-31 23:35:38 -0600 FBE8093B756374D82BDCB2923CCE30A77654BF03AFFBA5BE77F6C35E096E7FFB Rating Details
2023-02-01 15:12:49 -0600 Rating Details
2023-02-01 05:06:07 -0600 Rating Details
2023-02-03 15:30:01 -0600 Rating Details
2023-01-31 17:53:24 -0600 Rating Details
2023-01-31 23:59:58 -0600 Rating Details
2023-01-31 23:40:38 -0600 Rating Details
2023-01-31 18:03:28 -0600 Rating Details
2023-01-31 22:12:12 -0600 Rating Details
2023-01-31 17:51:00 -0600 Rating Details
2023-02-01 01:39:55 -0600 Rating Details
2023-01-31 16:41:37 -0600 Rating Details
2023-01-31 22:31:00 -0600 Rating Details
2023-02-01 05:06:07 -0600 Rating Details
2023-01-31 17:19:09 -0600 Rating Details
2023-02-01 04:23:38 -0600 Rating Details
2023-01-31 21:40:31 -0600 Rating Details
2023-02-01 01:33:12 -0600 Rating Details
2023-01-31 22:34:00 -0600 Rating Details
2023-01-31 23:35:38 -0600 Rating Details
2023-02-03 15:30:01 -0600 Rating Details
2023-02-01 04:28:16 -0600 Rating Details
2023-02-01 00:16:57 -0600 Rating Details
2023-01-31 17:53:24 -0600 Rating Details
2023-01-31 20:01:23 -0600 Rating Details
2023-02-01 00:30:00 -0600 Rating Details
2023-01-31 22:10:31 -0600 Rating Details
2023-02-01 00:33:00 -0600 Rating Details
2023-01-31 17:12:46 -0600 Rating Details
2023-01-31 17:11:54 -0600 Rating Details
2023-01-31 19:31:06 -0600 Rating Details
2023-02-01 01:25:05 -0600 Rating Details
2023-01-31 18:26:53 -0600 Rating Details
2023-02-01 02:30:15 -0600 Rating Details
2023-01-31 23:09:22 -0600 Rating Details
2023-02-03 08:07:10 -0600 Rating Details
2023-02-01 02:33:24 -0600 Rating Details
2023-01-31 22:20:40 -0600 Rating Details
2023-02-01 01:19:33 -0600 Rating Details
2023-01-31 17:39:26 -0600 Rating Details
2023-02-01 00:01:42 -0600 Rating Details
2023-01-31 22:06:01 -0600 Rating Details
2023-01-31 17:25:51 -0600 Rating Details
2023-01-31 16:42:25 -0600 Rating Details
2023-02-01 05:24:55 -0600 Rating Details
2023-02-01 15:12:49 -0600 Rating Details
2023-02-01 00:17:14 -0600 Rating Details